Status:
UNKNOWN
Personalized Evidence-based Treatment in Patients With Invasive Breast Cancer
Lead Sponsor:
Center of Personalized Medicine, Pirogova
Collaborating Sponsors:
Center for New Medical Technologies, Novosibirsk, Russia
I.M. Sechenov First Moscow State Medical University
Conditions:
Breast Cancer-specific Survival
Eligibility:
FEMALE
Up to 70 years
Brief Summary
A population-based case-cohort study of breast cancer-specific survival among all first invasive breast cancer cases
Eligibility Criteria
Inclusion
- All women with stage I-III disease who survived at least 12 months post-diagnosis
Exclusion
- Unknown cause of death Treatment outside the region (thus precluding the treatment assessment)
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 30 2021
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT04798976
Start Date
March 1 2021
End Date
May 30 2021
Last Update
March 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Evgeny Pokushalov
Novosibirsk, Russia, 630090